RGT 8.62% 26.5¢ argent biopharma limited

Ann: Patients Begin Treatment in Clinical Trial of CogniCann, page-6

  1. 1,078 Posts.
    lightbulb Created with Sketch. 122
    awful time to have an SPP out on market - Brett may have to kick in!!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.